Posts
A Small Collection of Articles to Understand the Green Revolution
(And why someone is opposing a second one)
Marked as Myth?
Just me and my clumsy critique on the practice of labeling arguments as “myths” in scientific discourse.
For Genetic Privacy
Personal genetic information is getting easier to access and easier to decode; opening massive opportunities to cure and prevent diseases, but raising privacy concerns.
Shaking the Habitual - (almost) part 2: Seed Markets and Open Source
Breeders rights, food justice, ecology and open source. A collection of topics to contextualize and discuss the Open Source Seed Licenses
Who Submits Plant Varieties to the European Register?
If you want to market a plant variety as seeds or reproductive material, you must register that plant variety to certify that it is distinct, uniform and stable and that it has a potential value for cultivation. The European plant variety registration process has been criticized for favoring big companies, and thus, accentrating the seed market in few hands. I explored the European Register of Varieties to check which plant seed is allowed in the market and which company holds the rights.
Shaking the Habitual - Part 1: Diversity Aimed Plant Breeding
A plant breed is easy to grow when it behaves in a uniform and expected way. But uniformity don’t agree much with biodiversity, how can we balance the two?
Intents and Targets for this Blog
Setting targets and intents for this blog, which I will use to explore how genetics, the technologies of the life science, and their underlying policies and regulations, influence our life, our work and our society.
Agricultural Holdings and workers in Europe
In Europe there are 11 Million agricultural holdings and “only” 22 Million people working on them: 2 per holding. Using data from Eurostat, can we get more details on agricultural workers and where they are distributed?
The Case of Generic Medicines
Developing a medicine costs money, which companies must gain back by selling it. But medicines must be available to those in need regardless of their price. This is why governments allow bioequivalent medicines; but can we ask for a better option?